Wille Finance

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

T3 Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, founded in 2015. The company focuses on the research and development of bacteria-based therapies specifically designed for cancer treatment. Recognizing the ongoing need for innovative solutions in oncology, T3 Pharmaceuticals aims to enhance the lives of cancer patients by creating highly specific and efficient treatments using live bacteria. Through its work, the company seeks to address the limitations of conventional therapies and contribute to the advancement of novel cancer medicines.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company based in Schlieren, Switzerland, founded in 2014. The company specializes in the discovery and development of novel human immunomodulatory proteins aimed at enhancing cancer treatment and addressing autoimmune diseases. By focusing on next-generation therapeutics, ImmunOs aims to create drugs that not only exhibit direct anti-tumor effects but also remodel the tumor microenvironment. Additionally, the company is developing antibodies designed to block the activation of specific HLA molecules associated with autoimmune conditions. Through its innovative approach, ImmunOs Therapeutics seeks to improve the lives of patients suffering from serious diseases.

Labiotech UG operates a biotechnology news Website. Its Website provides news in the areas of health, non-health, research, start-up, finance, and market access; and features news, such as reviews, interviews, tops, biotech of the week, and inside news. The company also provides advertising opportunities. It provides biotechnology news of various locations, including Austria, Belgium, France, Germany, Luxemburg, the Netherlands, Switzerland, Denmark, Finland, Iceland, Ireland, Sweden, Norway, the United Kingdom, Israel, Italy, Portugal, Spain, Turkey, Poland, Slovakia, and Czech Republic. Labiotech UG was founded in 2014 and is based in Berlin, Germany.

Nezasa AG operates a travel booking platform focused on individual travelers in Asia, providing a comprehensive solution for creating, personalizing, and booking travel packages. Founded in 2012 and based in Zurich, Switzerland, Nezasa enables customers to book various services, including hotels, transfers, and activities, catering to both economy and business class travelers. The platform is designed for flexibility, allowing users to adjust itineraries in real time to meet their preferences while maintaining consistency and managing the complexity of travel arrangements. Additionally, Nezasa offers tailored services for specific interests, such as golfing and short leisure trips for business travelers originating from Shanghai. Through its innovative software solutions, Nezasa aims to enhance the travel experience by facilitating seamless booking and providing opportunities for in-destination upselling.

Nezasa AG operates a travel booking platform focused on individual travelers in Asia, providing a comprehensive solution for creating, personalizing, and booking travel packages. Founded in 2012 and based in Zurich, Switzerland, Nezasa enables customers to book various services, including hotels, transfers, and activities, catering to both economy and business class travelers. The platform is designed for flexibility, allowing users to adjust itineraries in real time to meet their preferences while maintaining consistency and managing the complexity of travel arrangements. Additionally, Nezasa offers tailored services for specific interests, such as golfing and short leisure trips for business travelers originating from Shanghai. Through its innovative software solutions, Nezasa aims to enhance the travel experience by facilitating seamless booking and providing opportunities for in-destination upselling.